Crossmark

HIV prevention is not all about HIV – using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection

Crossref DOI link: https://doi.org/10.1186/s12879-020-05399-4

Published Online: 2020-09-25

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vickerman, Peter http://orcid.org/0000-0002-8291-5890
Quaife, Matthew

Kilbourne-Brook, Maggie

Mvundura, Mercy

Eakle, Robyn

Terris-Prestholt, Fern
Funding

Funding for this research was provided by:

United States Agency for International Development (#AID-OAA-A-11-00051)

Programme Development Grants (Health Protection Research Unit in Evaluation of Interventions)

Bill and Melinda Gates Foundation (OPP1084416)
License Information

Text and Data Mining valid from 2020-09-25

Version of Record valid from 2020-09-25
More Information

Article History

Received: 16 March 2020

Accepted: 6 September 2020

First Online: 25 September 2020

Ethics approval and consent to participate

: The study was approved by the University of the Witwatersrand Human Research Ethics Committee and the Research Ethics Committee at the London School of Hygiene and Tropical Medicine. All participation in the Discrete Choice Experiment, alongside supporting qualitative studies, was voluntary and subject to completion of written informed consent.

: Not applicable.

: The authors report no conflicts of interest.

Document is current

Any future updates will be listed below